1. Home
  2. ALCO vs PBYI Comparison

ALCO vs PBYI Comparison

Compare ALCO & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alico Inc.

ALCO

Alico Inc.

N/A

Current Price

$41.49

Market Cap

267.7M

Sector

N/A

ML Signal

N/A

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$5.67

Market Cap

263.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALCO
PBYI
Founded
1960
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
267.7M
263.4M
IPO Year
1994
2011

Fundamental Metrics

Financial Performance
Metric
ALCO
PBYI
Price
$41.49
$5.67
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
23.3K
373.9K
Earning Date
05-11-2026
05-29-2026
Dividend Yield
0.48%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.61
Revenue
N/A
$27,685,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$21.66
Revenue Growth
N/A
N/A
52 Week Low
$27.02
$2.58
52 Week High
$43.20
$7.68

Technical Indicators

Market Signals
Indicator
ALCO
PBYI
Relative Strength Index (RSI) 59.56 35.21
Support Level $39.99 $5.64
Resistance Level $43.20 $6.15
Average True Range (ATR) 0.97 0.39
MACD -0.08 -0.06
Stochastic Oscillator 73.86 8.28

Price Performance

Historical Comparison
ALCO
PBYI

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: